Elizabeth Joy Stapper is a Houston, Texas based female rheumatologist who is specialized in Rheumatology. Active license number of Elizabeth Joy Stapper is PA15587 in Texas. Elizabeth Joy Stapper treat joint disease similar to orthopedists but do not perform surgeries. She diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Elizabeth Joy Stapper speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Credentials:
PA-C
Gender:
Female
Practice Address:
522 Timberdale Ln, Houston, Texas, 77090-3063
Phone:
281-440-5006
Fax:
281-719-5935
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1427708981
NPI Enumeration Date:
28 Mar, 2022
NPI Last Update On:
12 May, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elizabeth Joy Stapper are as mentioned below.
License Number
Specialization
State
Status
PA15587
Texas
Primary
PA15587
Rheumatology
Texas
Secondary
PA15587
Physician Assistant
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
129 Vision Park Blvd, Shenandoah, Texas
Zip:
77384-3023
Phone Number:
281-315-8130
Fax Number:
--
Patients can reach Elizabeth Joy Stapper at 522 Timberdale Ln, Houston, Texas or can call to book an appointment on 281-440-5006. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.